An Integrated Bioinformatics Approach Identifies Elevated Cyclin E2 Expression and E2F Activity as Distinct Features of Tamoxifen Resistant Breast Tumors
Table 2
Common enriched GO terms in the three over-expressed gene sets in tamoxifen resistant tumors.